284 related articles for article (PubMed ID: 36134916)
1. Immunomodulation, Toxicity, and Therapeutic Potential of Nanoparticles.
Pandey A; Mishra AK
BioTech (Basel); 2022 Sep; 11(3):. PubMed ID: 36134916
[TBL] [Abstract][Full Text] [Related]
2. Effects of engineered nanoparticles on the innate immune system.
Liu Y; Hardie J; Zhang X; Rotello VM
Semin Immunol; 2017 Dec; 34():25-32. PubMed ID: 28985993
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulatory and immune-toxicological role of nanoparticles: Potential therapeutic applications.
Sau S; Dey A; Pal P; Das B; Maity KK; Dash SK; Tamili DK; Das B
Int Immunopharmacol; 2024 Jun; 135():112251. PubMed ID: 38781608
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the toxicity of selected types of nanochemicals.
Kumar V; Kumari A; Guleria P; Yadav SK
Rev Environ Contam Toxicol; 2012; 215():39-121. PubMed ID: 22057930
[TBL] [Abstract][Full Text] [Related]
5. Structural parameters of nanoparticles affecting their toxicity for biomedical applications: a review.
Abbasi R; Shineh G; Mobaraki M; Doughty S; Tayebi L
J Nanopart Res; 2023; 25(3):43. PubMed ID: 36875184
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, biomedical applications, and toxicity of CuO nanoparticles.
Naz S; Gul A; Zia M; Javed R
Appl Microbiol Biotechnol; 2023 Feb; 107(4):1039-1061. PubMed ID: 36635395
[TBL] [Abstract][Full Text] [Related]
7. Overview on experimental models of interactions between nanoparticles and the immune system.
Najafi-Hajivar S; Zakeri-Milani P; Mohammadi H; Niazi M; Soleymani-Goloujeh M; Baradaran B; Valizadeh H
Biomed Pharmacother; 2016 Oct; 83():1365-1378. PubMed ID: 27580456
[TBL] [Abstract][Full Text] [Related]
8. Behavior and Potential Impacts of Metal-Based Engineered Nanoparticles in Aquatic Environments.
Peng C; Zhang W; Gao H; Li Y; Tong X; Li K; Zhu X; Wang Y; Chen Y
Nanomaterials (Basel); 2017 Jan; 7(1):. PubMed ID: 28336855
[TBL] [Abstract][Full Text] [Related]
9. Functional DNA Molecules Enable Selective and Stimuli-Responsive Nanoparticles for Biomedical Applications.
Li L; Xing H; Zhang J; Lu Y
Acc Chem Res; 2019 Sep; 52(9):2415-2426. PubMed ID: 31411853
[TBL] [Abstract][Full Text] [Related]
10. Review on Metal-Based Nanoparticles: Role of Reactive Oxygen Species in Renal Toxicity.
Makhdoumi P; Karimi H; Khazaei M
Chem Res Toxicol; 2020 Oct; 33(10):2503-2514. PubMed ID: 32909744
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulation of nanoparticles in nanomedicine applications.
Jiao Q; Li L; Mu Q; Zhang Q
Biomed Res Int; 2014; 2014():426028. PubMed ID: 24949448
[TBL] [Abstract][Full Text] [Related]
12. Toxicity Concerns of Therapeutic Nanomaterials.
Singla R; Sharma C; Shukla AK; Acharya A
J Nanosci Nanotechnol; 2019 Apr; 19(4):1889-1907. PubMed ID: 30486930
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticle-induced immune response: Health risk versus treatment opportunity?
Pondman K; Le Gac S; Kishore U
Immunobiology; 2023 Mar; 228(2):152317. PubMed ID: 36592542
[TBL] [Abstract][Full Text] [Related]
14. Comparative safety analysis of bactericidal nano-colloids: Assessment of potential functional toxicity and radical scavenging action.
Hashmi MU; Khalid N; Alam T; Hanif R; Janjua HA
Colloids Surf B Biointerfaces; 2019 Dec; 184():110508. PubMed ID: 31546223
[TBL] [Abstract][Full Text] [Related]
15. The comparative immunotoxicity of mesoporous silica nanoparticles and colloidal silica nanoparticles in mice.
Lee S; Kim MS; Lee D; Kwon TK; Khang D; Yun HS; Kim SH
Int J Nanomedicine; 2013; 8():147-58. PubMed ID: 23326190
[TBL] [Abstract][Full Text] [Related]
16. Toxicity evaluation of engineered nanoparticles for medical applications using pulmonary epithelial cells.
Guadagnini R; Moreau K; Hussain S; Marano F; Boland S
Nanotoxicology; 2015 May; 9 Suppl 1():25-32. PubMed ID: 24286383
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticles in clinical trials of COVID-19: An update.
Rauf A; Abu-Izneid T; Khalil AA; Hafeez N; Olatunde A; Rahman M; Semwal P; Al-Awthan YS; Bahattab OS; Khan IN; Khan MA; Sharma R
Int J Surg; 2022 Aug; 104():106818. PubMed ID: 35953020
[TBL] [Abstract][Full Text] [Related]
18. Modulation of immune responses with nanoparticles and reduction of their immunotoxicity.
Muhammad Q; Jang Y; Kang SH; Moon J; Kim WJ; Park H
Biomater Sci; 2020 Mar; 8(6):1490-1501. PubMed ID: 31994542
[TBL] [Abstract][Full Text] [Related]
19. Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine.
Du JZ; Li HJ; Wang J
Acc Chem Res; 2018 Nov; 51(11):2848-2856. PubMed ID: 30346728
[TBL] [Abstract][Full Text] [Related]
20. Nanotherapeutics: An insight into healthcare and multi-dimensional applications in medical sector of the modern world.
Prasad M; Lambe UP; Brar B; Shah I; J M; Ranjan K; Rao R; Kumar S; Mahant S; Khurana SK; Iqbal HMN; Dhama K; Misri J; Prasad G
Biomed Pharmacother; 2018 Jan; 97():1521-1537. PubMed ID: 29793315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
